TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The "Global Ibuprofen Arginine Market" was valued at US$ 362.5 million in 2024 and is projected to reach US$ 621.5 million by 2030, at a CAGR of 9.4% during the forecast period.
The global key manufacturers of Ibuprofen Arginine include Newstar Chem Enterprise, Chemos, BuGuCh and Partners, Aozeal Certified Standards, LEAPChem, Spedifen, Pipelinepharma, Solpharma and Zambon, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Ibuprofen arginate is the more soluble arginate salt form of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen. Ibuprofen arginate retains the inhibitory potency against COX-2 as ibuprofen and its sodium salt, however only ibuprofen arginate is able to augment cellular NO pathway through codelivery of the NOS substrate arginine.
This report aims to provide a comprehensive presentation of the global market for Ibuprofen Arginine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ibuprofen Arginine. This report contains market size and forecasts of Ibuprofen Arginine in global, including the following market information:
We has surveyed the Ibuprofen Arginine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
By Type:
By Application:
By Region and Country:
Competitor Analysis
The report also provides analysis of leading market participants including:
Key Players Include:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ibuprofen Arginine, market overview.
Chapter 2: Global Ibuprofen Arginine market size in revenue and volume.
Chapter 3: Detailed analysis of Ibuprofen Arginine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ibuprofen Arginine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ibuprofen Arginine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.